Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 19, 2012 08:00 ET | Source: National Association of People with AIDS

NAPWA, TAEP to Urge Congress to Implement Healthcare Reform, End Federal Bans Targeting HIV-Positive Americans at AIDSWatch 2012

WASHINGTON, DC--(Marketwire - Apr 19, 2012) - Today the National Association of People with AIDS (NAPWA) and the Treatment Access Expansion Project (TAEP) announces AIDSWatch 2012, the largest...
April 06, 2012 09:40 ET | Source: National Association of People with AIDS

NAPWA's "Healthy Living Summit," Largest National Conference by and for People Living With HIV, to Convene in Dallas April 10 - 13

WASHINGTON, DC and DALLAS, TX--(Marketwire - Apr 6, 2012) - The National Association of People with AIDS (NAPWA) today announced that it will host the first annual National Healthy Living Summit...
March 06, 2012 14:30 ET | Source: Laurantis Pharma OY

Research Team Discovers Four-Fold Improvement in Ability to Restore Lymphatic Function With Adenovirally-Delivered VEGF-C Gene Therapy After Lymph Node Transplant Surgery Compared to the Surgery Alone

VENTURA, CA--(Marketwire - Mar 6, 2012) - Lymphedema Awareness Day was established to support the needs of patients with lymphedema and to raise awareness for the need to develop new treatment...
February 15, 2012 08:00 ET | Source: Bionor Pharma

With Final Review of Phase IIb Viral Load Data Completed, Researchers Confirm Statistically Significant Reduction of HIV Viral Load on Vacc-4x Compared to Placebo

OSLO, NORWAY--(Marketwire - Feb 15, 2012) - Bionor Pharma (OSLO: BIONOR) News Summary Final review of phase IIb data confirms statistically significant 64%...
January 23, 2012 08:00 ET | Source: Bionor Pharma

With Final Documentation Submitted for International Patent Applications, Bionor Sees Promise of Two Core Platform Technologies

OSLO, NORWAY--(Marketwire - Jan 23, 2012) - News Summary Bionor Pharma ASA has previously submitted two international patent applications for the Company's...
January 04, 2012 08:00 ET | Source: Bionor Pharma

Researchers Study Nasal Administration of Bionor Pharma's Therapeutic HIV Vaccine Vacc-4x Combined With Eurocine Vaccines' Endocine(TM) in Fully Enrolled Trial; New Treatment Option Would Offer Easier Treatment Access for HIV Patients Globally

OSLO, NORWAY--(Marketwire - Jan 4, 2012) - News Summary Bionor Pharma's Vacc-4x is an investigational therapeutic HIV vaccine that has already shown in a...
November 22, 2011 08:00 ET | Source: Bionor Pharma

Bionor Pharma's Universal Influenza Vaccine, Vacc-Flu, Targets Regions Shared by All Influenza A Strains; Reduces Serious Flu Symptoms by 25 Percent Over Standard Flu Vaccine in Animal Study

ARLINGTON, VA--(Marketwire - Nov 22, 2011) - Summary of Findings Bionor's Vacc-Flu could be "Universal," meaning that it could work on seasonal flu and also on...
November 15, 2011 09:10 ET | Source: VIRxSYS Corporation

VIRxSYS Issued U.S. Patents for Its Lentiviral Vector and SMaRT RNA Platforms

GAITHERSBURG, MD--(Marketwire - Nov 15, 2011) - VIRxSYS Corporation, a Maryland-based biotechnology company, today announced that the United States Patent and Trademark Office has issued two...
September 27, 2011 12:00 ET | Source: National Association of People with AIDS

NAPWA Announces New HIV Initiative to Combat Transmission Rates in the District of Columbia; New Program Will Target the Approximately 10,000 HIV Positive District Residents Currently Unaware of Their Status

WASHINGTON, DC--(Marketwire - Sep 27, 2011) - Frank Oldham Jr., President and CEO of the National Association of People With AIDS (NAPWA), today announced participation in a program that will use...
September 23, 2011 10:23 ET | Source: Laurantis Pharma

Lymfactin(TM):in on todettu merkittävästi lisäävän imusuonien kasvua eläintutkimuksessa; Tulokset nähdään ’tienä läpimurtoon’ rintasyöpäpotilailla, jotka hyötyisivät imusolmukesiirroista lymfedeeman vuoksi

MALMO, SWEDEN--(Marketwire - Sep 23, 2011) - Laurantis Pharma, yksityisomisteinen bioteknologiayhtiö, joka toimii Suomessa, ilmoitti tänään, että Lymfactin(TM),...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right